Track Record 2017

1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017



Our covered positions for the Newsletter Portfolio are below.
70% have been for GAINS of 50% or GREATER.

REWALK ROBOTICS. Closed position at $1.81 for a 64% GAIN.

CARDIOME PHARMA. Closed position at $4.26 for a 55% GAIN.

ARBUTUS BIOPHARMA. Closed position at $3.74 for a 52% GAIN.

VERASTEM, INC. Closed position at $2.06 for a 62% GAIN.

SYNACOR, INC. Closed position at $4.24 for a 52% GAIN.

HTG MOLECULAR DIAGNOSTICS. Closed position at $4.74 for a 63% GAIN.

AURINIA PHARMACEUTICALS. Closed position at $5.50 for a 78% GAIN.

INTERNAP CORPORATION. Closed position at $3.39 for a 51% GAIN.

PIERIS PHARMACEUTICALS. Closed position at $2.49 for a 54% GAIN.

SONOMA PHARMACEUTICALS. Closed position at $7.24 for a 52% GAIN.
(price reflects reverse stock split)

REXAHN PHARMACEUTICALS. Closed position at $3.00 for a 68% LOSS.
(price reflects reverse stock split)

ONCONOVA THERAPEUTICS. Closed position at $2.10 for a 91% LOSS.
(price reflects reverse stock split)

EYEGATE PHARMACEUTICALS. Closed position at $2.70 for a 65% GAIN.

ACTINIUM PHARMACEUTICALS. Closed position at $1.67 for a 67% GAIN.

ROSETTA GENOMICS. Closed position at $4.08 for an 88% LOSS.
(price reflects reverse stock split)

MAST THERAPEUTICS. Closed position at 12¢ for an 80% LOSS.

GIGPEAK, INC. Closed position at $3.08 for a 45% GAIN.
(being acquired by IDT)

COMBIMATRIX CORPORATION. Closed position at $4.06 for a 53% GAIN.

CONATUS PHARMACEUTICALS. Closed position at $5.10 for a 126% GAIN.

MOSYS, INC. Closed position at $2.39 for an 88% LOSS.
(price reflects reverse stock split)

SIGNAL GENETICS. Closed position at $16.17 for a 25% LOSS.
(price reflects reverse stock split)

The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.

Forbes Directory - Best of the Web
Best of the Web
(Small Caps)
Barron's > read
review
As Featured:
*BARRON's
*CNNfn.com
*BusinessWeek Online
*Barron's Electronic Edition
InvestOnlineTrading

Ads From Google
Ads From Google